Table 1.

Baseline patient characteristics at initiation of CVVHDF

Characteristic	Standard dose (20 mg/kg/h)	High dose (35 mg/kg/h)	P
Patients (n)	83	82
Citrate anticoagulation	95	97	0.41
Age (years)	62 ± 14	59 ± 15	0.22
Male gender (%)	60	63	0.68
Weight (kg)	91 ± 18	94 ± 18	0.27
Creatinine (mg/dL)	4.2 ± 2.2	4.2 ± 1.6	0.92
BUN (mg/dL)	76 ± 40	77 ± 36	0.82
Urine output (mL/day)	611 ± 792	522 ± 574	0.40
APACHE II	26.0 ± 6.3	26.3 ± 5.9	0.76